Qianru Li | Epidemiology | Best Researcher Award

Mrs. Qianru Li | Epidemiology | Best Researcher Award

Recognition and Awards

Qianru’s work has not gone unnoticed, as evidenced by her receiving the ‘Frontrunner 5000’ award in 2023. This recognition underscores her impact and excellence in the field of cancer epidemiology.

Mrs. Qianru Li , Chinese Academy of Medical Sciences & Peking Union Medical College, China

Profile

Scopus

OrcID

📚 Early Academic Pursuits

Qianru Li completed her Bachelor of Medicine degree in Preventative Medicine from Sichuan University in 2022. Her academic foundation in preventative medicine set the stage for her specialized focus on cancer epidemiology. This rigorous training equipped her with the essential knowledge and skills necessary to address complex public health challenges, particularly in cancer prevention and early detection.

💼 Professional Endeavors

With over 7 years of experience in the public health field, Qianru Li has demonstrated a strong commitment to advancing cancer epidemiology. She is currently pursuing a PhD degree in Epidemiology and Biostatistics at the Chinese Academy of Medical Sciences and Peking Union Medical College. Her professional journey is marked by her involvement in significant research initiatives that aim to reduce the cancer burden through early detection strategies.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

  • Qianru Li’s research primarily focuses on cancer epidemiology, with a particular emphasis on screening and early detection. She has made notable contributions to the field, including the publication of four articles (with one pending publication) as the first author. These articles explore the burden and evolving trends of major cancers, including colorectal and liver cancer. Her work has been recognized with the prestigious ‘Frontrunner 5000’ award in 2023, underscoring her impact in the field.

🌟Impact and Influence

  • Qianru Li’s research has had a significant impact on the understanding and management of cancer. By focusing on early detection strategies, she is driving advancements that have the potential to save lives and reduce the overall cancer burden. Her insights into the epidemiology of cancer have informed public health policies and screening programs, making a lasting impact on the field.

📖 ACADEMIC CITES

Qianru Li’s work has garnered attention in academic circles, with her articles contributing valuable data and analysis to the field of cancer epidemiology. Her research has been cited by peers and has influenced ongoing studies in cancer screening and prevention. Her growing academic footprint is a testament to the relevance and quality of her work.

🌍 LEGACY AND FUTURE CONTRIBUTIONS

Qianru Li is poised to continue her contributions to the field of cancer epidemiology. Her ongoing research is expected to further refine early detection strategies, offering new hope in the fight against cancer. As she advances in her academic and professional career, her work will likely leave a lasting legacy, shaping future research and public health initiatives in cancer prevention.

📰PUBLICATIONS

  • The current infection with Helicobacter pylori and association with upper gastrointestinal lesions and risk of upper gastrointestinal cancer: Insights from multicenter population-based cohort study
    Authors: Yan, X., Zeng, H., Li, H., Xia, C., Chen, W.
    Journal: International Journal of Cancer, 2024, 155(7), pp. 1203–1211
  •  Survey of hepatitis B virus infection for liver cancer screening in China: A population-based, cross-sectional study
    Authors: Xu, Y., Xia, C., Li, H., Cao, M., Chen, W.
    Journal: Chinese Medical Journal, 2024, 137(12), pp. 1414–1420
  • Cancer statistics for young adults aged 20 to 49 years in China from 2000 to 2017: a population-based registry study
    Authors: Teng, Y., Xia, C., Li, H., Li, Q., Chen, W.
    Journal: Science China Life Sciences, 2024, 67(4), pp. 711–719
  •  Comparison of the epidemiological distribution of liver cancer in China, Japan, and South Korea
    Authors: Cao, M., Yang, F., Li, Q., Xia, C., Chen, W.
    Journal: Chinese Journal of Cancer Prevention and Treatment, 2024, 31(4), pp. 205–209
  •  Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors
    Authors: He, S., Xia, C., Li, H., Li, Q., Chen, W.
    Journal: Science China Life Sciences, 2024, 67(1), pp. 122–131